fingolimod hydrochloride has been researched along with B-Cell Lymphoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Archer, RL; Baltz, BP; Chacko, JA; Chacko, JG; Stout, PW; Strati, P | 1 |
| Boes, CJ; Colgan, JP; Flanagan, EP; Howard, MT; Stitt, DW | 1 |
| Bogen, B; Corthay, A; Lorvik, KB | 1 |
3 other study(ies) available for fingolimod hydrochloride and B-Cell Lymphoma
| Article | Year |
|---|---|
Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosis.
Topics: Adult; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2021 |
A Case of cutaneous large B-cell lymphoma during treatment of multiple sclerosis with fingolimod.
Topics: Aged; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphoma, B-Cell; Multiple Sclerosis; Skin Neoplasms | 2018 |
Fingolimod blocks immunosurveillance of myeloma and B-cell lymphoma resulting in cancer development in mice.
Topics: Animals; Disease Models, Animal; Fingolimod Hydrochloride; Immunologic Surveillance; Immunosuppressive Agents; Lymphoma, B-Cell; Mice; Mice, SCID; Mice, Transgenic; Multiple Myeloma; Propylene Glycols; Sphingosine | 2012 |